AstraZeneca PLC AZN:LSE Actions Health CarePharmaceuticals and Biotechnology Price (GBX)10,486.00 Today's Change-82.00 / -0.78% Shares traded476.00k 1 Year change+0.92% Beta0.3794 Data delayed at least 20 minutes, as of Dec 13 2024 13:51 GMT....
AstraZeneca Stock Forecast, AZN stock price prediction. Price target in 14 days: 10903.28 GBX. The best long-term & short-term AstraZeneca share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily AZN exchange price projections: monthly and
AstraZeneca PLC Stock Price History Beta (5Y Monthly)0.194636 52-Week Change24.14% S&P500 52-Week Change20.43% 52 Week High153.1 USD 52 Week Low104.5 USD 50-Day Moving Average147.43 USD 200-Day Moving Average132.36 USD AZNCF Share Statistics ...
healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq gold bitcoin market outlook today's market us economy gold & precious metals commodities forex editors...
Jim Cramer says to invest in companies that make things, at a profit, and return some of those profits to shareholders while maintaining a reasonable share price for its growth rate. NFLXDISJNJ Technology Business News Mar 16, 2022 10:23 PM EDT Novartis and Roche Have Expensive Drugs That ...
11:28aBarron'sThese Stocks Are Moving the Most Today: Tesla, MicroStrategy, Synopsys, SentinelOne, AeroVironment, American Airlines, Verint, and More 11:18aPicksYou can now get an annual Sam’s Club membership for $25 11:15aBitcoin breaks $100,000, boosted by Trump’s crypto embrace and...
“Today’s announcement reinforces AstraZeneca’s long-term commitment to diabetes, a core strategic area for us and an important platform for returning AstraZeneca to growth.” (Read more:) While Bristol-Myers’ CEO Lamberto Andreotti said the deal would enable the company to move to a more...
You can see the complete list of today’s Zacks #1 Rank stocks here. In the past 60 days, estimates for Arcturus Therapeutics’ 2024 loss per share have improved from $4.39 to $2.60. Estimates for 2025 have improved from a loss of 45 cents to earnings of 21 cents per share during the...
So we have to -- the assumption is the share of sales is not going to be the 20% we saw a few years ago. We are at 12%, 13% today, and the rest of the world will grow much more. So I guess what I'm saying is we will navigate this difficult period, and we think we can...
AstraZeneca is becoming a leader in the cancer therapeutics market, that's reflected in the growth of its share price. See why AZN stock continues to be a buy.